ArticleJACC. CardioOncology2020

Angiotensin Receptor-Neprilysin Inhibition for Doxorubicin-Mediated Cardiotoxicity: Time for a Paradigm Shift.

Virginia S Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.